Understanding Communications Included With COVID-19 (Corona Virus Disease of 2019) Home Testing Kits

Completed · Not applicable

Conditions studied: COVID-19 Testing, Decision Making

In brief

To test competing sets of information for consumers on how to interpret hypothetical SARS-CoV-2 home test kit results and whether they report plans to take CDC-recommended actions to protect themselves and others given their test results and two critical aspects of their clinical context: symptoms, recent close exposures. Participants will be randomized to receive either information from the FDA authorized Ellume home test kit (the first kit authorized for over the counter use) for what actions to take for a negative or positive COVID-19 test (usual care) or a decision science-based design of similar length (intervention).

Key facts

Study ID

NCT04758299

Run by

Barry Dewitt

People needed

360

Starts

2021-03-13

Expected to finish

2021-04-30

Last updated by the study team

2021-05-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participants must be >18 years old, communicate in English, reside in the United States.

You may not qualify if…

• Respondents who complete the survey in under a minute.

Where it is running

• Carnegie Mellon University — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.